These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8837283)

  • 1. Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy.
    Pastores GM; Hermann G; Norton KI; Lorberboym M; Desnick RJ
    Skeletal Radiol; 1996 Jul; 25(5):485-8. PubMed ID: 8837283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scintigraphic monitoring of reticuloendothelial system in patients with type 1 Gaucher disease on enzyme replacement therapy.
    Lorberboym M; Pastores GM; Kim CK; Hermann G; Glajchen N; Machac J
    J Nucl Med; 1997 Jun; 38(6):890-5. PubMed ID: 9189137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO
    J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
    Barton NW; Furbish FS; Murray GJ; Garfield M; Brady RO
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1913-6. PubMed ID: 2308952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement.
    Hermann G; Pastores GM; Abdelwahab IF; Lorberboym AM
    Skeletal Radiol; 1997 Dec; 26(12):687-96. PubMed ID: 9453101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease.
    Aharoni D; Krausz Y; Elstein D; Hadas-Halpern I; Zimran A
    Clin Nucl Med; 2002 Jul; 27(7):503-9. PubMed ID: 12072778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of various diagnostic methods in a patient with Gaucher disease type I.
    Farahati J; Trenn G; John-Mikolajewski V; Zander C; Pastores GM; Sciuk J; Reiners C
    Clin Nucl Med; 1996 Aug; 21(8):619-25. PubMed ID: 8853914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
    Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic evaluation of Tc-99m-low-density lipoprotein (LDL) distribution in patients with Gaucher disease.
    Lorberboym M; Vallabhajosula S; Lipszyc H; Pastores G
    Clin Genet; 1997 Jul; 52(1):7-11. PubMed ID: 9272706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaphyseal undertubulation in gaucher disease: resolution at MRI in a patient undergoing enzyme replacement therapy.
    Kelman CG; Disler DG
    J Comput Assist Tomogr; 2000; 24(1):173-5. PubMed ID: 10667678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of a proximal humeral defect in type-1 Gaucher disease by enzyme replacement therapy.
    Pastores GM; Hermann G; Norton K; Desnick RJ
    Pediatr Radiol; 1995; 25(6):486-7. PubMed ID: 7491212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology.
    Siddiqui AR; Oseas RS; Wellman HN; Doerr DR; Baehner RL
    J Nucl Med; 1979 May; 20(5):379-86. PubMed ID: 232146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease.
    Mariani G; Molea N; La Civita L; Porciello G; Lazzeri E; Ferri C
    Eur J Nucl Med; 1996 Apr; 23(4):466-70. PubMed ID: 8612670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow relaxation times in Gaucher disease before and after enzyme replacement therapy.
    Magnaldi S; Longo R; Ukmar M; Zanatta M; Bottega M; Sottocasa GL
    Eur Radiol; 1997; 7(4):486-91. PubMed ID: 9204325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Labeled Leukocyte and Technicium 99 Sulfur Colloid Bone Marrow Imaging: Differentiating Primary Pyomyositis Pseudotumor from Osteomyelitis and Multiple Bone Infarcts.
    Perdue PW; Spitzer AB; Chatterjee D; Kolla S; Maheshwari AV
    J Long Term Eff Med Implants; 2018; 28(1):17-24. PubMed ID: 29772988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
    Mikosch P; Kohlfürst S; Gallowitsch HJ; Kresnik E; Lind P; Mehta AB; Hughes DA
    Nuklearmedizin; 2008; 47(6):239-47. PubMed ID: 19057797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone, bone marrow, and MIBI scintigraphic findings in Gaucher's disease "bone crisis".
    Blocklet D; Abramowicz M; Schoutens A
    Clin Nucl Med; 2001 Sep; 26(9):765-9. PubMed ID: 11507294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of bone marrow imaging in childhood malignancies.
    Oseas RS; Siddiqui AR; Wellman HN; Baehner RL
    J Pediatr; 1982 Aug; 101(2):206-9. PubMed ID: 6284900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
    de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
    Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
    [No Abstract]   [Full Text] [Related]  

  • 20. Pelvic lesion simulated by asymmetric marrow uptake following umbilical artery injection of technetium-99m sulfur colloid.
    Vachon L; Colletti P
    Clin Nucl Med; 1986 Dec; 11(12):872. PubMed ID: 3815986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.